I now have comprehensive data from multiple authoritative rheumatology textbooks. Let me compile the full answer.
Differential Diagnosis and Diagnostic Workup: Rheumatoid Arthritis
Part A: Differential Diagnosis - Prioritized by Clinical Features
Rheumatoid arthritis (RA) is a clinical diagnosis - no single finding or test is pathognomonic. A broad differential must be considered in any patient presenting with joint pain, swelling, and morning stiffness. Below, conditions are grouped by likelihood and the specific clinical features that raise or lower suspicion for RA.
Tier 1 - Conditions Most Likely to Mimic RA (Must Exclude First)
| Condition | Features Suggesting This Diagnosis | Features that FAVOR RA Over This |
|---|
| Viral Arthritis (Parvovirus B19, Hep B/C, Rubella, Chikungunya, EBV) | Acute onset; rash; fever; self-limited (<6 weeks for most); travel history; recent infection | Symptoms >6 weeks; positive RF/ACPA; symmetric small joint swelling without rash |
| Systemic Lupus Erythematosus (SLE) | Nonerosive arthritis (Jaccoud's arthropathy); positive ANA/anti-dsDNA; malar rash; oral ulcers; renal, pulmonary, CNS involvement; ACPA negative | Erosive arthritis; ACPA positive; RF strongly positive without ANA subserologies |
| Psoriatic Arthritis | Psoriatic skin/nail changes; dactylitis ("sausage fingers"); DIP joint involvement; asymmetric; HLA-B27+; RF/ACPA negative | Symmetric small-joint polyarthritis; positive ACPA; no skin/nail disease |
| Spondyloarthropathy (ReA, AS, IBD-associated) | Male predominance; oligoarticular, large joint/lower extremity distribution; low back pain; HLA-B27+; uveitis; RF/ACPA negative; preceding GI or STI | Symmetric polyarthritis of small joints of hands/feet; ACPA positive |
- Firestein & Kelley's Textbook of Rheumatology, 2-Vol Set, Table 72.2
- Goldman-Cecil Medicine, Table 243-2
Tier 2 - Conditions Requiring Careful Exclusion
| Condition | Discriminating Features |
|---|
| Polymyalgia Rheumatica (PMR) | Shoulder and hip girdle pain/stiffness in elderly (>50 yrs); markedly elevated ESR/CRP; RF/ACPA negative; dramatic response to low-dose prednisone; association with giant cell arteritis |
| Sjogren's Syndrome | Keratoconjunctivitis sicca (dry eyes), xerostomia (dry mouth); salivary gland enlargement; positive ANA, anti-SSA/SSB; often RF+ but ACPA negative; nonerosive |
| Adult-onset Still's Disease | Quotidian fever >39 degrees C for >1 week; evanescent salmon-pink rash; leukocytosis with >80% PMNs; arthralgias; lymphadenopathy; splenomegaly; markedly elevated serum ferritin |
| Crystalline Arthropathy (Gout, CPPD) | Gout: hyperuricemia, tophi (may mimic nodular RA), monoarthritis initially, podagra; CPPD: chondrocalcinosis on X-ray; crystal identification on synovial fluid analysis; RF/ACPA negative |
| Sarcoidosis | Acute form: erythema nodosum + bilateral hilar adenopathy (Lofgren's syndrome); predilection for ankles; often RF+ but ACPA negative; noncaseating granulomas on biopsy; nonerosive |
- Rheumatology, 2-Volume Set (Elsevier, 2022), Section 90
- Goldman-Cecil Medicine, Table 243-2
Tier 3 - Less Common but Important Mimics
| Condition | Key Points |
|---|
| Bacterial Endocarditis | High fever; predominantly large joints; audible heart murmur; positive blood cultures; embolic phenomena; can be RF+; ACPA negative |
| RS3PE Syndrome (Remitting Seronegative Symmetric Synovitis with Pitting Edema) | Elderly men; synovial thickening + pitting edema of hands; very responsive to glucocorticoids; RF/ACPA negative; associated with occult malignancy |
| Fibromyalgia | Widespread myalgia without true inflammatory arthritis; normal ESR, CRP, RF, ACPA; no synovitis on examination |
| Osteoarthritis (erosive) | DIP/PIP involvement; Heberden's/Bouchard's nodes; no morning stiffness >30 min; normal inflammatory markers; RF/ACPA negative |
| Paraneoplastic arthritis | Fulminant onset in elderly; consider in RF-negative cases; search for underlying malignancy |
| Hypothyroidism | Causes rheumatic manifestations AND co-occurs with RA; always check TSH in new polyarthritis |
- Rheumatology, 2-Volume Set (Elsevier, 2022)
- Goldman-Cecil Medicine, 2022
Part B: Clinical Features That Point Toward RA (Aetiology-Specific)
The following cluster of features should raise strong suspicion for RA as the primary diagnosis:
- Joint pattern: Symmetric polyarthritis involving small joints of the hands (MCPs, PIPs), wrists, and MTPs - the PIPs and MCPs are the classic targets; DIPs are typically spared (distinguishing from OA)
- Morning stiffness: Lasting >1 hour, improving with movement - reflects synovial inflammation
- Age/sex: Female predominance (F:M = 3:1); typical onset between ages 30-60
- Chronicity: Symptoms present >6 weeks (excludes most viral arthritides)
- Seropositivity: Positive RF and/or ACPA (anti-CCP) - together positive in ~80% of RA patients
- Extraarticular features: Rheumatoid nodules (over olecranon, Achilles); secondary Sjogren's; pulmonary nodules
- Absence of features suggesting alternatives: No psoriatic plaques, no malar rash, no dactylitis, no urethritis, no preceding infection
"A patient older than 18 years who has symmetric joint pain, swelling in the hands and feet, and morning stiffness is likely to have RA, especially if RF or ACPA is positive." - Rheumatology, 2-Volume Set (Elsevier 2022)
Part C: Diagnostic Workup for Presumed Rheumatoid Arthritis
1. Serological Tests
| Test | Interpretation |
|---|
| Rheumatoid Factor (RF) | Positive in ~70% at diagnosis; additional 15% seroconvert early. Low specificity - also positive in Hep C, Sjogren's, endocarditis. |
| Anti-Citrullinated Protein Antibodies (ACPA/anti-CCP) | Sensitivity similar to RF; specificity >95% for RA. Highly specific - key diagnostic test. May be positive years before clinical onset. |
| ANA | Up to 30% of RA patients may be low-titre positive; absence of positive subserologies (anti-dsDNA, anti-Sm) distinguishes from SLE |
| Anti-dsDNA, anti-Sm | Order to exclude SLE when ANA is positive |
| ANCA | Consider if vasculitis is suspected |
| Anti-SSA/SSB | Exclude Sjogren's syndrome |
- Firestein & Kelley's Textbook of Rheumatology, 2-Vol Set
2. Acute Phase Reactants / Inflammatory Markers
| Test | Findings in RA |
|---|
| ESR | Typically elevated (<50 mm/hr in early RA); may be normal in up to one-third of patients at first evaluation |
| CRP (C-Reactive Protein) | Typically elevated; more sensitive than ESR for active inflammation; used to monitor disease activity and treatment response |
| CBC | Normochromic normocytic anaemia of chronic disease; thrombocytosis in active disease; leukopenia suggests SLE |
| LFTs, Renal function | Baseline before initiating DMARDs (methotrexate, leflunomide); exclude organ-based mimics |
| Serum ferritin | Markedly elevated in Adult Still's disease (helps exclude) |
3. Imaging
| Modality | Findings / Role |
|---|
| Plain Radiographs (Hands and Feet) | First-line imaging: may show periarticular osteoporosis, joint space narrowing, marginal erosions at MCP/PIP/MTP joints, wrists. Often normal early in disease. Baseline for tracking structural damage. |
| Musculoskeletal Ultrasound (MSUS) | Detects synovitis and erosions not visible on X-ray; can assess power Doppler signal as marker of active synovitis; useful in early/seronegative RA |
| MRI (Hands/Wrists) | Most sensitive - detects bone marrow oedema, early erosions, and tenosynovitis before radiographic changes appear. Reserved for diagnostic uncertainty or to guide early treatment decisions. |
| CXR | Screen for pulmonary involvement (interstitial lung disease, pleural effusion, nodules); essential baseline |
"Musculoskeletal ultrasound and MRI can detect early evidence of synovitis and erosions not seen on radiographs, although the aim today is to prevent joint damage from occurring." - Rheumatology, 2-Volume Set (Elsevier 2022), p.803
4. Synovial Fluid Analysis (if arthrocentesis performed)
| Parameter | Findings in RA |
|---|
| WBC count | 5,000-25,000 cells/mm3 (inflammatory range); PMNs 60-80% |
| Culture | Negative (positive = septic arthritis) |
| Crystal analysis | Negative (positive = gout/CPPD) |
| PMN count | <90% (>90% PMN suggests infectious arthritis) |
| Ragocytes | May be present (phagocytic cells with immune complex granules) - not specific |
| Mucin clot test | No clot or friable clot (reduced hyaluronic acid) |
"Higher WBC and PMN counts in synovial fluid are more indicative of an infectious or crystalline etiology." - Firestein & Kelley's Textbook of Rheumatology
5. Additional Tests to Exclude Specific Differentials
| Test | Purpose |
|---|
| Hepatitis B and C serology | Viral arthritis mimic; Hep C causes false positive RF |
| Parvovirus B19 IgM | Acute viral polyarthritis (especially in young adults/those with rash) |
| TSH (Thyroid function) | Hypothyroidism mimics and co-occurs with RA |
| Uric acid | Elevated in gout (note: may be normal during acute attack) |
| Calcium pyrophosphate | Chondrocalcinosis on X-ray for CPPD |
| Serum ACE, chest CT | If sarcoidosis is suspected |
| Blood cultures | If bacterial endocarditis is suspected |
| HIV serology | Oligoarthritis in high-risk patients |
| HLA-B27 | Spondyloarthropathy suspected |
| Complement (C3, C4) | Low in SLE, normal/high in RA |
6. 2010 ACR/EULAR Classification Criteria (Score-Based Diagnosis)
A score of >=6/10 classifies a patient as having RA:
| Domain | Score |
|---|
| Joint involvement: 1 large joint = 0; 2-10 large = 1; 1-3 small = 2; 4-10 small = 3; >10 joints (at least 1 small) = 5 | 0-5 |
| Serology: Negative RF AND ACPA = 0; Low-positive RF OR ACPA = 2; High-positive RF OR ACPA = 3 | 0-3 |
| Acute phase reactants: Normal CRP AND ESR = 0; Abnormal CRP OR ESR = 1 | 0-1 |
| Duration of symptoms: <6 weeks = 0; >=6 weeks = 1 | 0-1 |
These criteria were developed to enable earlier diagnosis of RA compared with the 1987 ACR criteria (which required more long-standing disease features), allowing timely DMARD initiation before joint destruction occurs. - Firestein & Kelley's Textbook of Rheumatology, Table 72.4
Summary Workup Algorithm
Suspected RA (symmetric polyarthritis, small joints, >6 weeks, morning stiffness)
|
v
SEROLOGY: RF, ACPA, ANA (+subserologies if ANA+), Hep B/C, Parvovirus IgM
|
v
INFLAMMATION: ESR, CRP, CBC, metabolic panel (LFTs, creatinine)
|
v
IMAGING: X-ray hands/feet (bilateral); CXR
| (if early/seronegative/diagnostic uncertainty)
v
MSUS or MRI of hands/wrists
|
v
If effusion present: ARTHROCENTESIS (cell count, culture, crystals)
|
v
Apply 2010 ACR/EULAR criteria; score ≥6 = RA confirmed
Sources:
- Firestein & Kelley's Textbook of Rheumatology, 2-Vol Set (Tables 72.2, 72.3, 72.4)
- Rheumatology, 2-Volume Set, Elsevier 2022 (Chapter 90)
- Goldman-Cecil Medicine, International Edition (Table 243-2)
- Lippincott Illustrated Reviews: Pharmacology (Clinical Application 40.1)